These genetically complex cancers include angiosarcomas (hemangiosarcomas in dogs), fibrosarcomas, and histiocytomas. Recent advances in immunohistochemistry, cytogenetics, and molecular genetic analysis have allowed a clinically relevant division of STS to improve diagnosis and treatment